Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous ReAssessment With Flexible ExTension in Rare Malignancies - CRAFT: The NCT-PMO-1602 Phase II Trial

NCT04551521 is registered in ClinicalTrials.gov with German Cancer Research Center as lead sponsor.

NCT NCT04551521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04551521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous ReAssessment With Flexible ExTension in Rare Malignancies - CRAFT: The NCT-PMO-1602 Phase II Trial
Lead sponsor
German Cancer Research Center
Phase
Phase 2
Overall status
Completed
Start date
October 13, 2021
Completion date
December 30, 2024
Enrollment
72 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic or locally advanced malignancies